May 10 |
Castle Biosciences’ IDgenetix® Test Receives 2024 MedTech Breakthrough Award for "Best Overall Mental Health Solution"
|
May 8 |
Largest Prospective Study to Date Further Supports Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with DecisionDx-UM Class Result
|
May 7 |
Wall Street Analysts Predict a 36.09% Upside in Castle Biosciences (CSTL): Here's What You Should Know
|
May 6 |
Castle Biosciences (CSTL) is on the Move, Here's Why the Trend Could be Sustainable
|
May 5 |
Earnings Beat: Castle Biosciences, Inc. (NASDAQ:CSTL) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
|
May 5 |
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2024 Earnings Call Transcript
|
May 4 |
Castle Biosciences, Inc. (CSTL) Q1 2024 Earnings Call Transcript
|
May 3 |
DecisionDx®-SCC Significantly Improves Prediction Accuracy of Metastatic Events after Mohs Surgery in New Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Tumors of the Head and Neck
|
May 2 |
Castle Biosciences Inc (CSTL) Q1 2024 Earnings: Surpasses Revenue Forecasts and Raises Annual ...
|
May 2 |
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates
|